Roger D. Weiss

24.3k total citations · 2 hit papers
351 papers, 17.3k citations indexed

About

Roger D. Weiss is a scholar working on Epidemiology, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Roger D. Weiss has authored 351 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Epidemiology, 104 papers in Psychiatry and Mental health and 103 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Roger D. Weiss's work include Substance Abuse Treatment and Outcomes (158 papers), Opioid Use Disorder Treatment (97 papers) and Schizophrenia research and treatment (74 papers). Roger D. Weiss is often cited by papers focused on Substance Abuse Treatment and Outcomes (158 papers), Opioid Use Disorder Treatment (97 papers) and Schizophrenia research and treatment (74 papers). Roger D. Weiss collaborates with scholars based in United States, Canada and United Kingdom. Roger D. Weiss's co-authors include Lisa M. Najavits, Margaret L. Griffin, Steven M. Mirin, Sarah Shaw, Shelly F. Greenfield, R. Kathryn McHugh, Garrett M. Fitzmaurice, Jennifer Sharpe Potter, Larry R. Muenz and Kathleen M. Carroll and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Roger D. Weiss

342 papers receiving 16.4k citations

Hit Papers

Combined Pharmacotherapies and Behavioral Interventions f... 2006 2026 2012 2019 2006 2011 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger D. Weiss United States 72 6.7k 5.2k 3.9k 3.8k 2.3k 351 17.3k
Edward V. Nunes United States 66 5.6k 0.8× 3.0k 0.6× 4.0k 1.0× 2.7k 0.7× 2.5k 1.1× 378 13.8k
Kathleen T. Brady United States 84 5.2k 0.8× 9.6k 1.8× 2.6k 0.7× 3.8k 1.0× 4.2k 1.8× 478 23.7k
Kathleen M. Carroll United States 86 8.9k 1.3× 7.9k 1.5× 3.6k 0.9× 3.9k 1.0× 3.4k 1.5× 364 23.8k
George Woody United States 65 8.1k 1.2× 3.7k 0.7× 4.8k 1.2× 2.2k 0.6× 1.2k 0.5× 228 14.7k
Shane Darke Australia 71 9.6k 1.4× 3.6k 0.7× 7.6k 1.9× 1.8k 0.5× 1.6k 0.7× 304 17.7k
S. Patricia Chou United States 45 6.7k 1.0× 6.9k 1.3× 1.5k 0.4× 2.5k 0.7× 1.2k 0.5× 73 16.8k
Kathleen K. Bucholz United States 81 9.8k 1.5× 9.3k 1.8× 2.3k 0.6× 3.1k 0.8× 3.5k 1.5× 461 26.3k
Wilson M. Compton United States 71 9.2k 1.4× 6.3k 1.2× 6.7k 1.7× 2.7k 0.7× 1.9k 0.8× 250 23.9k
Bruce J. Rounsaville United States 87 9.5k 1.4× 10.2k 2.0× 3.6k 0.9× 5.2k 1.4× 4.3k 1.9× 314 25.4k
Henry R. Kranzler United States 88 10.8k 1.6× 5.1k 1.0× 2.7k 0.7× 3.3k 0.9× 8.2k 3.6× 610 28.2k

Countries citing papers authored by Roger D. Weiss

Since Specialization
Citations

This map shows the geographic impact of Roger D. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger D. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger D. Weiss more than expected).

Fields of papers citing papers by Roger D. Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger D. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger D. Weiss. The network helps show where Roger D. Weiss may publish in the future.

Co-authorship network of co-authors of Roger D. Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Roger D. Weiss. A scholar is included among the top collaborators of Roger D. Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger D. Weiss. Roger D. Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zanarini, Mary C., Christina M. Temes, Frances R. Frankenburg, et al.. (2025). The 24‐year course of substance use disorders in patients with borderline personality disorder and personality‐disordered comparison subjects. American Journal on Addictions. 34(4). 422–432.
2.
Sugarman, Dawn E., et al.. (2025). Menstrual Pain and Substance Use in Women Receiving Inpatient Treatment for Substance Use Disorders. Journal of Addiction Medicine. 19(5). 628–630.
3.
Ahmad, N. Jia, et al.. (2024). Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients. American Journal on Addictions. 33(6). 631–640. 1 indexed citations
4.
Castillo, Felipe, Mei‐Chen Hu, Ying Liu, et al.. (2023). Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances. Drug and Alcohol Dependence. 251. 110926–110926. 2 indexed citations
5.
Gardiner, Paula, et al.. (2023). Effects of live-online, group mindfulness training on opioid use and anxiety during buprenorphine treatment: A comparative effectiveness RCT. Contemporary Clinical Trials. 137. 107417–107417. 3 indexed citations
6.
Suzuki, Joji, Bianca Martin, David Smelson, et al.. (2023). A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial. Journal of Addiction Medicine. 17(5). 604–607. 3 indexed citations
7.
McHugh, R. Kathryn, et al.. (2023). Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019. American Journal on Addictions. 33(3). 283–289. 6 indexed citations
8.
Suzuki, Joji, et al.. (2022). Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study. SHILAP Revista de lepidopterología. 1(1). 157–163. 10 indexed citations
9.
Provost, Scott E., et al.. (2022). Correlates of optimism among patients in substance use disorder inpatient treatment. American Journal on Addictions. 31(6). 494–501. 3 indexed citations
10.
McCarthy, Julie M., Roger D. Weiss, Kim T. Mueser, et al.. (2022). Pilot development and feasibility of telehealth Community Reinforcement and Family Training (CRAFT) for early psychosis and substance use. Psychiatry Research. 317. 114804–114804. 6 indexed citations
11.
Schuman‐Olivier, Zev, Timothy B. Creedon, David Roll, et al.. (2022). Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study. American Journal on Addictions. 32(3). 244–253. 9 indexed citations
12.
Weiner, Scott G., Michelle A. Hendricks, Grant A. Ritter, et al.. (2022). Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone. PLoS ONE. 17(4). e0266561–e0266561. 4 indexed citations
13.
King, Christopher D., Shelly F. Greenfield, R. Kathryn McHugh, et al.. (2020). Anxiety sensitivity and grit as mediators between childhood abuse and relapse risk for substance use. Child Abuse & Neglect. 107. 104568–104568. 6 indexed citations
14.
Pedrelli, Paola, Brian Borsari, Jennifer E. Merrill, et al.. (2019). Evaluating the combination of a Brief Motivational Intervention plus Cognitive Behavioral Therapy for Depression and heavy episodic drinking in college students.. Psychology of Addictive Behaviors. 34(2). 308–319. 14 indexed citations
15.
Suzuki, Joji, Jennifer A. Johnson, Mary W. Montgomery, et al.. (2019). Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. Journal of Addiction Medicine. 14(4). 282–286. 23 indexed citations
16.
Welsh, Justine W., et al.. (2018). Review: Adjunctive pharmacologic approaches for benzodiazepine tapers. Drug and Alcohol Dependence. 189. 96–107. 17 indexed citations
17.
Suzuki, Joji, Jeffrey DeVido, D. Kalra, et al.. (2014). Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. American Journal on Addictions. n/a–n/a. 3 indexed citations
18.
Zuo, Lingjun, Henry R. Kranzler, Xingguang Luο, et al.. (2008). Interaction between Two Independent CNR1 Variants Increases Risk for Cocaine Dependence in European Americans: A Replication Study in Family-Based Sample and Population-Based Sample. Neuropsychopharmacology. 34(6). 1504–1513. 37 indexed citations
19.
Ziedonis, Douglas, David Smelson, Richard N. Rosenthal, et al.. (2005). Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations. Journal of Psychiatric Practice. 11(5). 315–339. 137 indexed citations
20.
Giacometti, Marco, Roger D. Weiss, & Hans Geyer. (1993). Histologische Untersuchungen zur Entwicklung der Milchdrüse bei trächtigen Alpensteingeissen (Capra i. ibexw L.). 58(3). 144–154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026